Prevalence of an inherited cancer predisposition syndrome associated with the germ line TP53 R337H mutation in Paraguay

Cancer Epidemiology
Edith Falcon-de LegalBonald C Figueiredo

Abstract

The tumor suppressor gene TP53 is the most frequently mutated gene in human cancer, and the germline TP53 R337H mutation is the most common mutation reported to date. However, this mutation is associated with a lower cumulative lifetime cancer risk than other mutations in the p53 DNA-binding domain. A detailed statistical analysis of 171,500 DNA tests in Brazilian neonates found that 0.27% of the general population is positive for this mutation, and some of the estimated 200,000 Brazilian R337H carriers in southern and southeastern Brazil have already developed cancer. The present study was designed to estimate R337H prevalence in neighboring Paraguay. To address this question, 10,000 dried blood samples stored in Guthrie cards since 2008 were randomly selected from the Paraguayan municipalities located at the border with Brazil. These samples were tested for R337H mutation using the PCR-restriction fragment length polymorphism assay. This germline mutation was detected in five samples (5/10,000), indicating that the total number of R337H carriers in Paraguay may be as high as 3500. Previous studies have shown that other countries (i.e., Portugal, Spain, and Germany) presented one family with this mutation, leading us to conclu...Continue Reading

References

Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·R C RibeiroR Sandrini
Mar 12, 2005·Arquivos brasileiros de endocrinologia e metabologia·Emilia M PintoAna Claudia Latronico
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie TinatThierry Frébourg
Dec 16, 2011·The Journal of Clinical Endocrinology and Metabolism·Leonie J M HerrmannStefanie Hahner
Jun 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gislaine CustódioBonald C Figueiredo
Jul 24, 2014·The Breast Journal·Juliana GiacomazziPatricia Ashton-Prolla

❮ Previous
Next ❯

Citations

Sep 25, 2016·Cold Spring Harbor Perspectives in Medicine·Maria Isabel Achatz, Gerard P Zambetti
Jul 17, 2020·Molecular Biology Reports·José Antonio da Silva FeitosaElvis Terci Valera

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.